These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29530786)

  • 1. The Bladder Utility Symptom Scale: A Novel Patient Reported Outcome Instrument for Bladder Cancer.
    Perlis N; Krahn MD; Boehme KE; Alibhai SMH; Jamal M; Finelli A; Sridhar SS; Chung P; Gandhi R; Jones J; Tomlinson G; Bremner KE; Kulkarni G
    J Urol; 2018 Aug; 200(2):283-291. PubMed ID: 29530786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and performance of the Functional Assessment of Cancer Therapy-Bladder (FACT-Bl) among advanced urothelial cancer patients.
    Degboe A; Ivanescu C; Rohay JM; Turner RR; Cella D
    Support Care Cancer; 2019 Nov; 27(11):4189-4198. PubMed ID: 30825026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer.
    Gilbert SM; Dunn RL; Hollenbeck BK; Montie JE; Lee CT; Wood DP; Wei JT
    J Urol; 2010 May; 183(5):1764-9. PubMed ID: 20299056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of quality of life, information, and supportive care needs in patients with muscle and non-muscle invasive bladder cancer across the illness trajectory.
    Chung J; Kulkarni GS; Morash R; Matthew A; Papadakos J; Breau RH; Guttman D; Bender J; Jones JM
    Support Care Cancer; 2019 Oct; 27(10):3877-3885. PubMed ID: 30767131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health related quality of life in patients with bladder cancer: a cross-sectional survey and validation study of the Hungarian version of the Bladder Cancer Index.
    Hevér NV; Péntek M; Balló A; Gulácsi L; Baji P; Brodszky V; Damásdi M; Bognár Z; Tóth G; Buzogány I; Szántó Á
    Pathol Oncol Res; 2015 Jul; 21(3):619-27. PubMed ID: 25434791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life in Long-term Survivors of Muscle-Invasive Bladder Cancer.
    Mak KS; Smith AB; Eidelman A; Clayman R; Niemierko A; Cheng JS; Matthews J; Drumm MR; Nielsen ME; Feldman AS; Lee RJ; Zietman AL; Chen RC; Shipley WU; Milowsky MI; Efstathiou JA
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1028-1036. PubMed ID: 27727064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI-18) in patients with advanced urothelial cancer.
    Peipert JD; Chang J; Li S; di Pietro A; Cislo P; Cappelleri JC; Cella D
    Cancer; 2024 Jan; 130(1):31-40. PubMed ID: 37823532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcome after radical cystectomy: translation and psychometric validation of the Swedish version of the Functional Assessment of Cancer Therapy Scale Vanderbilt Cystectomy Index.
    Stenzelius K; Lind AK; Wanegård J; Liedberg F
    Scand J Urol; 2016 Oct; 50(5):374-9. PubMed ID: 27376871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QUAlity of Life Assessment in Spina bifida for Adults (QUALAS-A): development and international validation of a novel health-related quality of life instrument.
    Szymanski KM; Misseri R; Whittam B; Raposo SM; King SJ; Kaefer M; Rink RC; Cain MP
    Qual Life Res; 2015 Oct; 24(10):2355-64. PubMed ID: 25863685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
    King MT; Stockler MR; O'Connell RL; Buizen L; Joly F; Lanceley A; Hilpert F; Okamoto A; Aotani E; Bryce J; Donnellan P; Oza A; Avall-Lundqvist E; Berek JS; Sehouli J; Feeney A; Berton-Rigaud D; Costa DSJ; Friedlander ML;
    Qual Life Res; 2018 Jan; 27(1):59-74. PubMed ID: 29248998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemorrhoidal Disease Symptom Score and Short Health ScaleHD: New Tools to Evaluate Symptoms and Health-Related Quality of Life in Hemorrhoidal Disease.
    Rørvik HD; Styr K; Ilum L; McKinstry GL; Dragesund T; Campos AH; Brandstrup B; Olaison G
    Dis Colon Rectum; 2019 Mar; 62(3):333-342. PubMed ID: 30451751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
    Salaffi F; Di Carlo M; Carotti M; Farah S
    Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ).
    Alexander M; Berger W; Buchholz P; Walt J; Burk C; Lee J; Arbuckle R; Abetz L
    Health Qual Life Outcomes; 2005 Oct; 3():67. PubMed ID: 16259630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a new patient-reported outcome instrument of health-related quality of life specific to patients with alcohol use disorder: the Alcohol Quality of Life Scale (AQoLS).
    Luquiens A; Whalley D; Laramée P; Falissard B; Kostogianni N; Rehm J; Manthey J; Paille F; Aubin HJ
    Qual Life Res; 2016 Jun; 25(6):1549-60. PubMed ID: 26589528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of utility measures for women with pelvic organ prolapse.
    Harvie HS; Lee DD; Andy UU; Shea JA; Arya LA
    Am J Obstet Gynecol; 2018 Jan; 218(1):119.e1-119.e8. PubMed ID: 28988907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
    Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
    Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of content validity for patient-reported outcome measures used in patients with non-muscle invasive bladder cancer: a systematic review.
    Rutherford C; Patel MI; Tait MA; Smith DP; Costa DSJ; King MT
    Support Care Cancer; 2018 Apr; 26(4):1061-1076. PubMed ID: 29392479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life quality evaluation in patients with bladder cancer: A systematic review.
    Mina S; Pardo Munevar CA; Osorio D; García-Perdomo HA
    Actas Urol Esp (Engl Ed); 2019 May; 43(4):198-204. PubMed ID: 30711312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring quality of life in patients with pleural mesothelioma using a modified version of the Lung Cancer Symptom Scale (LCSS): psychometric properties of the LCSS-Meso.
    Hollen PJ; Gralla RJ; Liepa AM; Symanowski JT; Rusthoven JJ
    Support Care Cancer; 2006 Jan; 14(1):11-21. PubMed ID: 15999264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.